PROTEON THERAPEUTICS INC

Profile

Company Names

PROTEON THERAPEUTICS INC

Addresses

200 WEST STREET, WALTHAM, MA 02451

Phone Numbers

781-890-0102

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$71,087,965.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2017-08-02 
$22,000,000.00 
$22,000,000.00 
$0.00 
Equity 
3
2014-05-13 
$29,565,934.00 
$29,565,934.00 
$0.00 
Equity 
2
2013-09-04 
$4,338,660.00 
$4,338,660.00 
$0.00 
Equity, Debt 
1
2011-08-02 
$15,183,371.00 
$15,183,371.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
HUBERT 
 
BIRNER 
DIRECTOR
HUBERT 
 
BIRNER, PH. D. 
DIRECTOR
STEVEN 
K. 
BURKE 
EXECUTIVE OFFICER
STEVEN 
K. 
BURKE, M.D. 
EXECUTIVE OFFICER
SCOTT 
A. 
CANUTE 
DIRECTOR
GEORGE 
 
ELDRIDGE 
EXECUTIVE OFFICER
GEORGE 
A. 
ELDRIDGE 
EXECUTIVE OFFICER
F. 
NICHOLAS 
FRANANO 
DIRECTOR
JOHN 
G. 
FREUND 
DIRECTOR
JOHN 
G. 
FREUND, M.D. 
DIRECTOR
DANIEL 
P. 
GOTTLIEB 
EXECUTIVE OFFICER
TIM 
 
HAINES 
DIRECTOR
PAUL 
J. 
HASTINGS 
DIRECTOR
TONY 
 
KINGSLEY 
DIRECTOR
DMITRY 
 
KOBYZEV 
DIRECTOR
MATTHEW 
P. 
KOWALSKY 
EXECUTIVE OFFICER
DAVID 
G. 
LOWE 
DIRECTOR
TIMOTHY 
 
NOYES 
EXECUTIVE OFFICER, DIRECTOR
TIMOTHY 
P. 
NOYES 
EXECUTIVE OFFICER, DIRECTOR
GREGORY 
D. 
PHELPS 
DIRECTOR
DEAN 
 
PROFIS 
EXECUTIVE OFFICER
E. 
SCOTT 
TONER 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2017-08-02 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-05-13 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2013-09-04 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-08-02 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#